S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
66,000% upside on tiny biotech? (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Laser breakthrough could send stock soaring 2,467% (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
Laser breakthrough could send stock soaring 2,467% (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
66,000% upside on tiny biotech? (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Laser breakthrough could send stock soaring 2,467% (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
Laser breakthrough could send stock soaring 2,467% (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
66,000% upside on tiny biotech? (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Laser breakthrough could send stock soaring 2,467% (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
Laser breakthrough could send stock soaring 2,467% (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
66,000% upside on tiny biotech? (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Laser breakthrough could send stock soaring 2,467% (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
Laser breakthrough could send stock soaring 2,467% (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
NASDAQ:SBOT

Stellar Biotechnologies (SBOT) Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$0.85
▼
$0.89
50-Day Range
$4.44
▼
$298,098.00
52-Week Range
$0.75
▼
$3.25
Volume
20,332 shs
Average Volume
2.95 million shs
Market Capitalization
$4.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileFinancialsHeadlinesSEC FilingsShort InterestSocial Media

SBOT stock logo

About Stellar Biotechnologies (NASDAQ:SBOT) Stock

Stellar Biotechnologies, Inc., a biotechnology company, engages in the aquaculture, research and development, manufacture, and commercialization of keyhole limpet hemocyanin (KLH) protein in Europe, North America, and Asia. The company offers KLH, an immune-stimulating protein used in the production of various immunotherapies; and as a carrier molecule or finished injectable product in the immunodiagnostic market. It provides its KLH protein under the Stellar KLH brand. The company's products include Stellar KLH protein in various grades, formulations, custom configurations, and fill finishes for drug development and research applications, as well as KLH-based in vitro diagnostic kits for research and preclinical use. Its customers and partners comprise biotechnology and pharmaceutical companies, academic institutions, clinical research organizations, and research centers. Stellar Biotechnologies, Inc. is based in Port Hueneme, California.


SBOT Stock News Headlines

July 30, 2023 | nypost.com
Zach Wilson’s stellar day at Jets camp includes long touchdown throw
June 7, 2023 | forbes.com
Caterpillar's Stellar Move To Attract High-Quality Employees
September 24, 2023 | Behind the Markets (Ad)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
February 26, 2023 | benzinga.com
Stellar Bancorp, Inc. Declares Quarterly Dividend
October 5, 2022 | cbsnews.com
O's closer Felix Bautista goes on DL ending stellar rookie year
November 16, 2020 | markets.businessinsider.com
News for Stellar Biotechnologies Inc Registered Shs
May 28, 2020 | www.bloomberg.com
Stellar Biotechnologies Announces Fiscal Year 2016 Corporate Update Conference Call
May 5, 2020 | www.bloomberg.com
Stellar Issues Statement on Favorable Clinical Study Results
September 24, 2023 | Behind the Markets (Ad)
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
March 22, 2020 | www.bloomberg.com
Stellar Achieves Robust Viral Clearance for Manufacturing Process
June 7, 2019 | seekingalpha.com
Stellar Bio completes reverse merger with Edesa Biotech
June 7, 2019 | finance.yahoo.com
Edesa Biotech and Stellar Biotechnologies Complete Business Combination
May 31, 2019 | www.benzinga.com
Mid-Day Market Update: Crude Oil Down 2.9%; Stellar Biotechnologies Shares Spike Higher
March 18, 2019 | www.nasdaq.com
Stellar Biotechnologies, Inc. Estimate Momentum
March 8, 2019 | seekingalpha.com
Stellar up 118% on reverse merger with Edesa Biotech
March 7, 2019 | finance.yahoo.com
What Kind Of Shareholders Own Stellar Biotechnologies, Inc. (NASDAQ:SBOT)?
January 18, 2019 | finance.yahoo.com
How Much Did Stellar Biotechnologies, Inc.’s (NASDAQ:SBOT) CEO Pocket Last Year?
See More Headlines
Receive SBOT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stellar Biotechnologies and its competitors with MarketBeat's FREE daily newsletter.

SBOT Company Calendar

Last Earnings
5/08/2019
Today
9/23/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SBOT
CUSIP
N/A
CIK
1540159
Web
www.stellarbiotechnologies.com
Phone
805-488-2800
Fax
N/A
Employees
25
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($1.76)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-5,030,000.00
Net Margins
-1,782.64%
Pretax Margin
N/A
Return on Equity
-51.12%
Return on Assets
-48.37%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.24
Quick Ratio
8.96

Sales & Book Value

Annual Sales
$210,000.00
Price / Sales
21.63
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.12 per share
Price / Book
0.40

Miscellaneous

Outstanding Shares
5,330,000
Free Float
N/A
Market Cap
$4.54 million
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover
A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for October 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Frank R. Oakes (Age 69)
    Chairman, Pres & CEO
  • Ms. Kathi Niffenegger CPA (Age 62)
    CFO & Corp. Sec.
  • Mr. Gary Koppenjan
    Sr. Director of Investor Relations & Communications
  • Brando Lincicum
    Exec. Director of Aquaculture and Facility Operations

Key Competitors

View All Competitors













SBOT Stock - Frequently Asked Questions

How were Stellar Biotechnologies' earnings last quarter?

Stellar Biotechnologies Inc (NASDAQ:SBOT) released its quarterly earnings results on Wednesday, May, 8th. The biotechnology company reported ($0.31) EPS for the quarter, missing the consensus estimate of ($0.26) by $0.05. The biotechnology company earned $0.12 million during the quarter, compared to analysts' expectations of $0.11 million. Stellar Biotechnologies had a negative net margin of 1,782.64% and a negative trailing twelve-month return on equity of 51.12%.

When did Stellar Biotechnologies' stock split?

Shares of Stellar Biotechnologies reverse split on Monday, May 7th 2018. The 1-7 reverse split was announced on Friday, April 27th 2018. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 4th 2018. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

What other stocks do shareholders of Stellar Biotechnologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Stellar Biotechnologies investors own include Heat Biologics (HTBX), XOMA (XOMA), Anavex Life Sciences (AVXL), EyePoint Pharmaceuticals (EYPT), OPKO Health (OPK), Rigel Pharmaceuticals (RIGL), Statoil ASA (STO), Abraxas Petroleum (AXAS) and Carrizo Oil & Gas (CRZO).

What is Stellar Biotechnologies' stock symbol?

Stellar Biotechnologies trades on the NASDAQ under the ticker symbol "SBOT."

What is Stellar Biotechnologies' stock price today?

One share of SBOT stock can currently be purchased for approximately $0.85.

How much money does Stellar Biotechnologies make?

Stellar Biotechnologies (NASDAQ:SBOT) has a market capitalization of $4.54 million and generates $210,000.00 in revenue each year. The biotechnology company earns $-5,030,000.00 in net income (profit) each year or ($1.76) on an earnings per share basis.

How can I contact Stellar Biotechnologies?

Stellar Biotechnologies' mailing address is 332 EAST SCOTT STREET, PORT HUENEME CA, 93041. The official website for the company is www.stellarbiotechnologies.com. The biotechnology company can be reached via phone at 805-488-2800 or via email at ir@stellarbiotech.com.

This page (NASDAQ:SBOT) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -